Description
Boron was founded in 1932 in Lyon, France, by twin brothers and pharmacists Jean and Henri Boron. As the world leader in homeopathic medicines, Boron is a $852 million public company with 3,700 employees and distribution in 59 countries. It is best known for Oscillococcinum, a top-selling flu medicine, and its Arnicare line of pain relievers. For more than 80 years, Boron has been committed to funding scientific research and educating the public and health care professionals on homeopathic medicines. As a pharmaceutical company, Boron maintains the highest standards in manufacturing, complying with U. S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.
